| 17.75 | -0.14 / -0.78% |
Data as of 4:00pm ET | Day’s Change |
| 17.75 | |
Volume: 394.00 |
The 7 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 24.00 and a low estimate of 17.00. The median estimate represents a +7.04% increase from the last price of 17.75.

The current consensus among 8 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




